Implications of personalized medicine—perspective from a cancer center

被引：0
|
作者：
Thomas Tursz
Fabrice Andre
Vladimir Lazar
Ludovic Lacroix
Jean-Charles Soria
机构：
[1] Institut Gustave Roussy,Department of Medical Oncology and INSERM U981
[2] Institut Genomic Unit,Department of Translational Research
[3] Institut Gustave Roussy,undefined
[4] Institut Gustave Roussy,undefined
来源：
Nature Reviews Clinical Oncology | 2011年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Modern challenges in oncology, in particular the advent of targeted therapies and personalized medicine, highlight the need for developing a consortium of comprehensive cancer centers to run clinical trials in rare, molecularly-defined populations, and implement high-throughput technologies for daily practice.
引用
收藏
页码：177 / 183
页数：6
相关论文
共 50 条
  • [1] Implications of personalized medicine-perspective from a cancer center
    Tursz, Thomas
    Andre, Fabrice
    Lazar, Vladimir
    Lacroix, Ludovic
    Soria, Jean-Charles
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 177 - 183
  • [2] Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
    Fernandez-Garza, Luis E.
    Dominguez-Vigil, Irma G.
    Garza-Martinez, Jose
    Valdez-Aparicio, Erick A.
    Barrera-Barrera, Silvia A.
    Barrera-Saldana, Hugo A.
    [J]. WORLD JOURNAL OF ONCOLOGY, 2021, 12 (04) : 85 - 92
  • [3] Implementing Personalized Medicine in a Cancer Center
    Fenstermacher, David A.
    Wenham, Robert M.
    Rollison, Dana E.
    Dalton, William S.
    [J]. CANCER JOURNAL, 2011, 17 (06): : 528 - 536
  • [4] Colon Cancer Biomarkers: Implications for Personalized Medicine
    Pritzker, Kenneth P. H.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04):
  • [5] Genetic Background of Patients from a University Medical Center in Manhattan: Implications for Personalized Medicine
    Tayo, Bamidele O.
    Teil, Marie
    Tong, Liping
    Qin, Huaizhen
    Khitrov, Gregory
    Zhang, Weijia
    Song, Quinbin
    Gottesman, Omri
    Zhu, Xiaofeng
    Pereira, Alexandre C.
    Cooper, Richard S.
    Bottinger, Erwin P.
    [J]. PLOS ONE, 2011, 6 (05):
  • [6] Building a Personalized Medicine Infrastructure at a Major Cancer Center
    Meric-Bernstam, Funda
    Farhangfar, Carol
    Mendelsohn, John
    Mills, Gordon B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15) : 1849 - 1857
  • [7] Educating for Personalized Medicine: A Perspective From Oncology
    Parkinson, D. R.
    Ziegler, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 23 - 25
  • [8] Prediction of Cancer Drug Resistance and implications for Personalized Medicine
    Volm, Manfred
    Efferth, Thomas
    [J]. FRONTIERS IN ONCOLOGY, 2015, 5
  • [9] From personalized to precision cancer medicine
    Baltagiannis, Evangelos G.
    Kyrochristos, Ioannis D.
    Ziogas, Demosthenes E.
    Goussia, Anna
    Mitsis, Michail
    Roukos, Dimitrios H.
    [J]. PERSONALIZED MEDICINE, 2020, 17 (04) : 245 - 250
  • [10] FROM PHARMACOGENETICS TO PERSONALIZED MEDICINE: A CUBAN REGULATORY PERSPECTIVE
    Remirez, D.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 83 - 83
12345